BioMarin Pharmaceutical Inc. buy Morgan Stanley
Start price
26.04.24
/
50%
€75.64
Target price
26.04.25
€104.69
Performance (%)
-6.66%
Price
14:13
€70.60
Summary
This prediction is currently active. With a performance of -6.66%, the BUY prediction by Morgan_Stanley is trending in the wrong direction. This prediction currently runs until 26.04.25. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
BioMarin Pharmaceutical Inc. | -7.012% |
iShares Core DAX® | -0.051% |
iShares Nasdaq 100 | 1.659% |
iShares Nikkei 225® | 0.658% |
iShares S&P 500 | 0.964% |
Comments by Morgan_Stanley for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Morgan Stanley from $115.00 to $112.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Morgan_Stanley for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€79.72
01.08.23
01.08.23
€113.91
01.08.24
01.08.24
-11.44%
14:13
14:13